Skip to main content

Table 3 Clinical characteristics of patients in blood analysis

From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1

Parameters Group 1a
(n = 4)
Group 2b
(n = 18)
Group 3c
(n = 6)
Group 4d
(n = 5)
Age (mean ± SD) 58.75 ± 12.12 61.05 ± 6.33 55.5 ± 6.16 60 ± 6.36
Sex
 Male 3 14 4 3
 Female 1 4 2 2
PVTTe
 Yes 0 6 2 1
 No 4 12 4 4
BCLCf
 A 2 5 2 1
 B 2 11 3 3
 C 0 2 1 1
Child–Pugh
 A 1 4 1 2
 B 3 13 5 3
 C 0 1 0 0
Milan criteria
Yes 1 2 1 1
No 3 16 5 4
Total tumor diameter (mm)
  < 30 1 3 1 0
30–50 2 2 3 4
  > 50 1 13 2 1
Number of lesions
1 4 17 5 4
2 0 1 1 1
  ≥ 3 0 0 0 0
  1. aGroup 1: normal-weight patients without HBV
  2. bGroup 2: normal-weight patients combined HBV
  3. cGroup 3: overweight patients without HBV
  4. dGroup 4: overweight patients combined HBV
  5. ePVTT Portal vein tumor thrombus
  6. fBCLC Barcelona Clinic Liver Cancer